These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8819661)

  • 1. Effect of anti-tuberculosis drugs on the iron-sequestration mechanisms of mycobacteria.
    Raghu B; Sarma GR; Venkatesan P
    Indian J Pathol Microbiol; 1995 Jul; 38(3):287-92. PubMed ID: 8819661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron on the growth and siderophore production of mycobacteria.
    Raghu B; Sarma GR; Venkatesan P
    Biochem Mol Biol Int; 1993 Oct; 31(2):341-8. PubMed ID: 8275022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemoglobin on the growth of mycobacteria and the production of siderophores.
    Raghu B; Sarma CR; Venkatesan P
    Indian J Pathol Microbiol; 1993 Oct; 36(4):376-82. PubMed ID: 8157304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of siderophores and envelope proteins from mycobacteria.
    Raghu B; Sarma GR
    Biochem Mol Biol Int; 1993 Oct; 31(2):333-9. PubMed ID: 8275021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utilization of siderophores from mycobacteria by Staphylococcus].
    Szarapińska-Kwaszewska J; Mikucki J
    Med Dosw Mikrobiol; 1998; 50(3-4):239-49. PubMed ID: 10222739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis.
    Ferreras JA; Ryu JS; Di Lello F; Tan DS; Quadri LE
    Nat Chem Biol; 2005 Jun; 1(1):29-32. PubMed ID: 16407990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall.
    Gobin J; Horwitz MA
    J Exp Med; 1996 Apr; 183(4):1527-32. PubMed ID: 8666910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins.
    Gobin J; Moore CH; Reeve JR; Wong DK; Gibson BW; Horwitz MA
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5189-93. PubMed ID: 7761471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs].
    Wang H; Chen Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):52-5. PubMed ID: 11802941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis.
    Palomino JC; Traore H; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron enhances the antituberculous activity of pyrazinamide.
    Somoskovi A; Wade MM; Sun Z; Zhang Y
    J Antimicrob Chemother; 2004 Feb; 53(2):192-6. PubMed ID: 14729751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.
    Chen P; Gearhart J; Protopopova M; Einck L; Nacy CA
    J Antimicrob Chemother; 2006 Aug; 58(2):332-7. PubMed ID: 16751637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobactin-mediated iron acquisition within macrophages.
    Luo M; Fadeev EA; Groves JT
    Nat Chem Biol; 2005 Aug; 1(3):149-53. PubMed ID: 16408019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of thiacetazone on mycobacterial species belonging to the Mycobacterium tuberculosis complex.
    Abate G; Koivula T; Hoffner SE
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):933-5. PubMed ID: 12365582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal analogues of mycobactin and exochelin fail to act as effective antimycobacterial agents.
    Barclay R; Ratledge C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):203-7. PubMed ID: 3097987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility testing of Mycobacterium tuberculosis complex strains isolated from seals to antituberculosis drugs.
    Bernardelli A; Morcillo N; Loureiro J; Quse V; Davenport S
    Biomedica; 2004 Jun; 24 Supp 1():85-91. PubMed ID: 15495576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.